Results 211 to 220 of about 92,115 (273)

Development of a multivariable prediction model for tumor response and treatment tolerance based on body composition dynamics in rectal cancer undergoing neoadjuvant chemoradiotherapy. [PDF]

J Gastrointest Oncol
Lee S, Kang DH, Ahn TS.
europepmc   +1 more source

Phase II randomized trial of 41.4 Gy vs. 50.4 Gy in neoadjuvant chemoradiotherapy for resectable esophageal cancer. [PDF]

Clin Transl Radiat Oncol
Esmati E, Nazari R, Aqamolaei A, Maddah Safaei A, Miri R, Shirkhoda M, Jalaeefar A, Salarvand S, Aghili M, Farhan F, Mousavi Darzikolaee N, Kolahdouzan K, Abyaneh R, Ghalehtaki R.   +13 more
europepmc   +1 more source

The predictive value of multi-phase contrast-enhanced MRI for pathological complete response after neoadjuvant chemoradiotherapy in rectal cancer. [PDF]

Front Oncol
Xie J, Lin K, Wu S, Lin J.
europepmc   +1 more source

Efficacy of HALP combined with T2-weighted MRI radiomics in predicting pathological complete response and overall survival in rectal cancer after neoadjuvant chemoradiotherapy: A retrospective single-center study in China. [PDF]

Medicine (Baltimore)
Wan X, Zhu C, Mei D, Liang L, Zhang S, Ge X, Sun X, Li Z, Di X, Xue N, Chen X.   +10 more
europepmc   +1 more source

Optimal surgical timing following neoadjuvant chemoradiotherapy in patients with rectal cancer: a systematic review and network meta-analysis. [PDF]

Am J Transl Res
Tao Z, Jiang Y, Gui Q, Ma J.
europepmc   +1 more source

Clinical Impact of Total Neoadjuvant Therapy Combined with Dose-Escalated Intensity-Modulated Radiotherapy for Lower Rectal Cancer: A Comparison with Conventional Neoadjuvant Chemoradiotherapy. [PDF]

Cancers (Basel)
Kawamura M, Toyomasu Y, Yamashita S, Ieki H, Imaoka H, Shimura T, Kitajima T, Okugawa Y, Okita Y, Ohi M, Nomoto Y, Toiyama Y.   +11 more
europepmc   +1 more source

Development and evaluation of an explainable machine learning selection pipeline for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer. [PDF]

J Transl Med
Xu Y, Gong W, Ji L, Xing Z, Zhu Z, Jin Z, Zhang J, Wang X, Qin S, Jiao Y, Wang L.   +10 more
europepmc   +1 more source

Comparison of perioperative chemotherapy and neoadjuvant chemoradiotherapy (CRT) in locally advanced resectable distal esophageal/esophagogastric junction (EGJ) adenocarcinomas. [PDF]

BMC Cancer
Şahin Çelik B, Ağdaş G, Genç V.
europepmc   +1 more source

Surveillance vs Standard Surgery and Cost-Effectiveness After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Secondary Analysis of a Randomized Clinical Trial.

JAMA Netw Open
Gangaram Panday SSG, van Klaveren D, Lagarde SM, van der Wilk BJ, Eyck BM, Rosman C, Noordman BJ, Valkema MJ, Bisseling TM, Coene PLO, Dekker JWT, van Det MJ, van Dieren JM, Doukas M, van Esser S, Fiets WE, Hartgrink HH, Heisterkamp J, Hol L, Klarenbeek B, Kouw E, Kouwenhoven EA, Luyer MD, Mostert B, Nieuwenhuijzen GAP, Oostenbrug LE, Oude Voshaar M, Pierie JP, van Sandick JW, Sosef MN, Spaander MCW, Steyerberg EW, Valkema R, van der Zaag ES, van Lanschot JJB, Lingsma HF, Wijnhoven BPL, Surgery as Needed for Oesophageal Cancer (SANO) Study Group.   +37 more
europepmc   +1 more source